Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Retinol Binding Protein RBP Antibody (RBP/872) - Azide and BSA Free, Novus Biologicals™

Mouse Monoclonal Antibody
Supplier: Novus Biologicals NBP2480170.1MG
Description
Retinol Binding Protein RBP Monoclonal specifically detects Retinol Binding Protein RBP in Human, Mouse, Rat, Goat, Monkey, Rabbit samples. It is validated for Immunohistochemistry, Immunohistochemistry-Paraffin.Specifications
Retinol Binding Protein RBP | |
Monoclonal | |
1.0 mg/mL | |
Immunohistochemistry-Paraffin : 1 - 2 ug/ml, Immunofluorescence : 1 - 2 ug/ml | |
C, Cellular retinol-binding protein, CRABP-I, CRBP1CRBP-I, CRBPCellular retinol-binding protein I, CRBPI, RBPC, retinol binding protein 1, cellular, retinol-binding protein 1, retinol-binding protein 1, cellular | |
Mouse | |
Protein A or G purified | |
RUO | |
5947 | |
Human, Mouse, Rat, Goat, Monkey, Rabbit | |
Purified |
Immunohistochemistry (Paraffin), Immunofluorescence | |
RBP/872 | |
Unconjugated | |
PBS with No Preservative | |
RBP1 | |
Recombinant human retinol binding protein-1 (RBP1) | |
0.1 mg | |
Primary | |
Recognizes a protein of 21kDa-25kDa, identified as retinol binding protein-1 (RBP1). This protein belongs to the lipocalin family and is the specific carrier for retinol (vitamin A alcohol) in the blood. It delivers retinol from the liver stores to the peripheral tissues. In plasma, the RBP-retinol complex interacts with transthyretin, which prevents its loss by filtration through the kidney glomeruli. A deficiency of vitamin A blocks secretion of the binding protein post-transnationally and results in defective delivery and supply to the epidermal cells. | |
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles. | |
IgG1 κ |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction